US Stock Futures Rise Slightly, Liquidia Corporation Shares Plunge After FDA Approval

US stock futures were slightly higher this morning, with the S&P 500 futures gaining around 0.1% on Monday. However, a notable dip occurred in pre-market trading for shares of Liquidia Corporation (LQDA). The company announced that the FDA granted tentative approval of YUTREPIA inhalation powder for treating adults with pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease. This news resulted in Liquidia shares plummeting 36.3% to $8.98 in pre-market trading.

Several other stocks also experienced losses in today’s pre-market trading session. YXT.COM GROUP HOLDING LIMITED (YXT) shares dropped 15.5% to $8.47 in pre-market trading after declining around 9% on Friday. Mereo BioPharma Group plc (MREO) shares fell 14.8% to $0.5609 in today’s pre-market trading after gaining 6% on Friday. Mereo BioPharma Group recently reported a quarterly loss of 2 cents per share.

BW LPG Limited (BWLP) shares declined 4.5% to $15.25 in pre-market trading. Shake Shack Inc. (SHAK) shares fell 3.6% to $103.51 after Piper Sandler analyst Brian Mullan downgraded Shake Shack from Overweight to Neutral. Serve Robotics Inc. (SERV) shares dropped 3.1% to $10.81 in pre-market trading. Serve Robotics recently announced a partnership with Shake Shack to deliver products using autonomous delivery robots through Uber Eats. Himalaya Shipping Ltd. (HSHP) shares fell 3% to $7.29 in pre-market trading. Applied Digital Corp (APLD) shares fell 2.7% to $3.90.

These pre-market fluctuations highlight the dynamic nature of the stock market and the impact of company announcements, analyst ratings, and market sentiment on individual stock performance.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top